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tc), hospitalyzed between september 08 and septem-
er 09 in a Hospital of Infectious Diseses from Eastern
omania. Double disc synergy test using cefotaxime and
moxicillin/clavulanic acid discs was used to screen ESBL
roducers and these strains were subsequently subjected to
onﬁrmatory Etest.
Results: E. coli resistance to cefotaxime, ceftazidime,
efoxitin, ciproﬂoxacin and imipenem was found to be 40,
9, 6, 30 and 1% respectively. Klebsiella resistance to cefo-
axime, ceftazidime, cefoxitin, ciproﬂoxacin and imipenem
as 70, 57, 22, 41 and 4% respectively. % of ESBL produc-
rs E. coli was 15% (97 strains) and Klebsiella was 38% (35).
ll the ESBL producing strains were susceptible in 100% to
mipenem and meropenem.
Conclusion: Carbapenems remain the most active agents
gainst Gram-negative isolates, including ESBL producers
train of E. coli and Klebsiella spp. isolated from community-
cquired and nosocomial infections from Eastern Romania.
oi:10.1016/j.ijid.2010.02.1575
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an we rely on automated VITEK2 system the detection
f KPC and other class A carbapenemase producers enter-
bacteriaceae?
. Pasteran ∗, C. lucero, R. soloaga, A. Corso
Instituto Nacional de Enfermedades Infecciosas ‘‘Dr. C. Mal-
rán’’, Buenos Aires, Argentina
Background: Class A carbapenemases have become more
revalent within Enterobacteriaceae. Proﬁcient methods
re needed for their early detection in clinical micro-
iology laboratories in any attempt aimed for targeting
ptimal antimicrobial therapy and controlling their spread.
utomated systems, as VITEK2, are increasingly used for
outine susceptibility testing to decrease the in-laboratory
urnaround time. However, the performance of VITEK2 for
he whole class A carbapenemase family detection has never
een assessed before. Objective: to determine the perfor-
ance of VITEK2 for carbapenemase detection compared
ith both, CLSI agar dilution MIC and the genotype obtained
y molecular methods.
Methods: Methods: we designed a panel composed by
iverse bacterial genera with distinct carbapenem suscep-
ibility patterns composed by 37 carbapenemase producers
nd 34 nonproducers (n): KPCs (17) Sme (10), NMC-A/IMI
2), GES (4), VIM/IMP (4) and CTX-M (12), AmpCs (12),
ombined mechanisms and others (10), respectively. The
esistance mechanisms of the strains were assessed by
CR/DNA sequencing. Each isolate was tested with the
ITEK2 using the AST-N082 cards speciﬁcally designed for
outh American countries (which included only imipenem
IPM- and meropenem -MEM-), according to the manufac-
urer’s instructions and by CLSI agar dilution MICs for both
arbapenems. Discrepant results were resolved by retesting
he isolates.
Results: Overall categorical interpretations with VITEK2
howed a 72% and 79% of agreement with reference MICs
or IPM and MEM, respectively. Very major (VM), major (MA)
nd minor (MI) errors were: IPM, VM 3%, MA 11% and MI 13%;
EM, VM 4%, MA 6% and MI 11%. Most of the errors (>80%)
g
(
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ccurred among carbapenemase producers. The expert sys-
em showed sensitivity (SN) of 76% and speciﬁcity (SP) of 87%
or carbapenemase detection, when confronted to the geno-
ype, with the greatest SN for KPCs (82%) and the lower for
BLs (25%). The recognition of suspected carbapenemase
roducers could be increased with the combined used of
PM and MEM with modiﬁed cut-off points of >=2.0mg/L and
=1.0mg/L, respectively (SN 97%, SP 90%).
Conclusion: VITEK2 may be suitable in clinical labora-
ories for Class A carbapenemase detection, but should
e accompanied with modiﬁcations in the cut-off used for
creening of suspected carbapenemase producers to ensure
heir proper detection.
oi:10.1016/j.ijid.2010.02.1576
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mergence of multidrugresistant gram negative bacilli
nd enterococci from rectal swabs of newborn and their
others from Central India
. Chitnis1, V. Chitnis2,∗, D. Chitnis1
Choithram Hospital and research center, Indore, India
Medical University of Americas, St James Parish, Saint
itts and Nevis
Background: Newborn babies acquire gut ﬂora mainly
rom mother and surrounding. We had observed in the faecal
amples of newborns prevalence, colonization of multidrug
esistant, ESBL pandrug resistant gram negative bacteria,
ancomycin resistant enterococci as a new threat in the
ewborn admitted in hospital.The inﬂux of these bacteria
nto hospitals has major implications for infection—control
nd empirical treatment strategies.
Methods: A total of 140 samples of faeces from neonates
nd mothers admitted in general maternity ward and ICU
f two hospital in central India were examined within
4-48 hours for presence of ESBL, pandrug resistant gram
egative bacilli, and vancomycin resistant
enterococci. Antibiotic susceptibility test were per-
ormed using Kirby-Bauer disc diffusion method and results
ere interpreted according to CLSI. Van A and ESBL gene
as conﬁrmed using E test, PCR and RT PCR.
Results: 1. A total of 48 E.coli, 49 Klebsiella, 21 Pseu-
omonas and 52 Entercocci isolates were obtained. The
ercentage of multidrug resistant E.coli, Klebsiella, Pseu-
omonas and enterococci was 78.79, 66.67, 58.8 and 91.18%
espectively. For gram negative bacilli % resistance for chlo-
amphenicol (47%), cabapenem 58.9% and ampicillin (74.3%)
minoglycosides (70.9%), quinolones (65.8%) and cefopara-
one+ sulbactum (58.1%). piperacillin+tazobactum (69.2%)
otrimoxazole (47%) cephalosporin (71.1%).The prevalence
f ESBL gene (TEM and SHV) among E.coli and Klebsiella
as 100% and 75% respectively. The pandrug resistant was
8.15% among E.coli and 20.4% among Klebsiella and 1.5%
mong Pseudomonas Of 52 enterococci, 47.06%. of them
ere vancomycin resistant strain and harboured van A gene.
nterococci were showing a high level resistance to amino-
lycosides (82.35%), ampicillin (82.35%), chloramphenicol
38.24%), teicoplanin (44.12%) and linezolid (8.82%).
Conclusion: We report high rates of colonization with
SBL and pandrug resistant gram negative organism and
